Combination PPARγ and RXR Agonist Treatment in Melanoma Cells: Functional Importance of S100A2

Nuclear hormone receptors, including RXR and PPARγ, represent novel therapeutic targets in melanoma. We have previously shown that the DRO subline of the amelanotic melanoma A375 responds to rexinoid and thiazolidinedione (TZD) treatment in vitro and in vivo. We performed microarray analysis of A375...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Klopper, Joshua P., Sharma, Vibha, Bissonnette, Reid, Haugen, Bryan R.
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi Publishing Corporation 2010
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2763133/
https://ncbi.nlm.nih.gov/pubmed/19859558
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2010/729876
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky